Donor human leukocyte antigen specific antibodies predict development and define prognosis in transplant glomerulopathy

Human Immunology

Volumn 72, Issue 5, 2011, Pages 386-391

  Eng, Hooi Sian ^a,b,c   Bennett, Greg ^c   Chang, Sean H ^b   Dent, Hannah ^b   McDonald, Stephen P ^b   Bardy, Peter ^a,b,c   Coghlan, Patrick ^c   Russ, Graeme R ^a,b,c   Coates, P Toby H ^a,b,c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

^c AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

Author keywords

Glomerulopathy; HLA antibodies; Renal transplant

Indexed keywords

ANTIMETABOLITE; AZATHIOPRINE; CYCLOSPORIN; HLA ANTIBODY; MYCOPHENOLIC ACID; STEROID;

ARTICLE; CONTROLLED STUDY; DELAYED GRAFT FUNCTION; GLOMERULOPATHY; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; ORGAN DONOR; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; TRANSPLANT GLOMERULOPATHY; UNIVARIATE ANALYSIS;

BIOLOGICAL MARKERS; DELAYED GRAFT FUNCTION; DISEASE PROGRESSION; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, MEMBRANOUS; GRAFT REJECTION; HLA ANTIGENS; HUMANS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 79954596918     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.02.002     Document Type: Article

References (27)

1. Sis B., Campbell P., Mueller T., Hunter C., Cockfield S., Cruz J., et al. Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant 2007, 7:1743-1752.
2. Wavamunno M., O'Connell P., Vitalone M., Fung C., Allen R., Chapman J., et al. Transplant glomerulopathy: ultrastructural abnormalities occur early in longitudinal analysis of protocol biopsies. Am J Transplant 2007, 7:2757-2768.
3. Gloor J., Sethi S., Stegall M., Park W., Moore S., DeGoey S., et al. Transplant glomerulopathy: subclinical incidence and association with alloantibody. Am J Transplant 2007, 7:2124-2132.
4. Sijpkens Y., Joosten S., Wong M., Dekker F., Benediktsson H., Bajema I., et al. Immunologic risk factors and glomerular C4d deposits in chronic transplant glomerulopathy. Kidney Int 2004, 65:2409-2418.
5. Issa N., Cosio F.G., Gloor J.M., Sethi S., Dean P.G., Moore S.B., et al. Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels. Transplantation 2008, 86:681-685.
6. Hood B., Olander R., Nagy Z., Bergentz S. Glomerulopathy in the transplanted kidney. Scand J Urol Nephrol 1970, 4:135-142.
7. Palomar R., López-Hoyos M., Pastor J.M., Fernández-Fresnedo G., Rodrigo E., Ruiz J.C., et al. Impact of HLA antibodies on transplant glomerulopathy. Transplant Proc 2005, 37:3830-3832.
8. Solez K., Colvin R., Racusen L., Sis B., Halloran P., Birk P., et al. Banff'05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ("CAN"). Am J Transplant 2007, 7:518-526.
9. Vongwiwatana A., Gourishankar S., Campbell P., Solez K., Halloran P. Peritubular capillary changes and C4d deposits are associated with transplant glomerulopathy but not IgA nephropathy. Am J Transplant 2004, 4:124-129.
10. Akalin E., Dikman S., Murphy B., Bromberg J., Hancock W. Glomerular infiltration by CXCR3+ ICOS+ activated T cells in chronic allograft nephropathy with transplant glomerulopathy. Am J Transplant 2003, 3:1116-1120.
11. Shimizu A., Yamada K., Yamamoto S., Lavelle J., Barth R., Robson S., et al. Thrombotic microangiopathic glomerulopathy in human decay accelerating factor-transgenic swine-to-baboon kidney xenografts. J Am Soc Nephrol 2005, 16:2732-2745.
12. Sayer D., Whidborne R., De Santis D., Rozemuller E., Christiansen F., Tilanus M. A multicenter international evaluation of single-tube amplification protocols for sequencing-based typing of HLA-DRB1 and HLA-DRB3, 4, 5. Tissue Antigens 2004, 63:412-423.
13. Chadban S., McDonald S., Chang S., Excell L., Livingston B. Chapter 8 Transplantation. The twenty ninth ANZDATA Registry report, Australia and New Zealand Dialysis and Transplant Registry 2006, 108-128. S. McDonald, S. Chang, L. Excell (Eds.).
14. Eng H., Bennett G., Tsiopelas E., Lake M., Humphreys I., Chang S., et al. Anti-HLA donor-specific antibodies detected in positive B-cell crossmatches by Luminex predict late graft loss. Am J Transplant 2008, 8:2335-2342.
15. Messias N., Eustace J., Zachary A., Tucker P., Charney D., Racusen L. Cohort study of the prognostic significance of acute transplant glomerulitis in acutely rejecting renal allografts. Transplantation 2001, 72:655-660.
16. Oliveira J., Monteiro M., Teixeira J., Osório E., Norton S., Alves H. Humoral immune response after kidney transplantation is enhanced by acute rejection and urological obstruction and is down-regulated by mycophenolate mofetil treatment. Transpl Int 2005, 18:1286-1291.
17. Ji S., Liu Z., Chen J., Sha G., Ji D., Li L. Rescue therapy by immunoadsorption in combination with tacrolimus and mycophenolate mofetil for C4d-positive acute humoral renal allograft rejection. Transplant Proc 2006, 38:3459-3463.
18. Sun Q., Tang Z., Chen J., Chen H., Liu Z., Li L. Late developing C4d-positive humoral renal allograft rejection associated with withdrawal of mycophenolate mofetil. Transplant Proc 2005, 37:4244-4245.
19. Wong H., Laberge R., Harvey E., Filler G. Preventing sensitization with mycophenolate mofetil in a pediatric kidney recipient. Pediatr Transplant 2006, 10:367-370.
20. Salama A., Delikouras A., Pusey C., Cook H., Bhangai G., Lechler R., et al. Transplant accommodation in highly sensitized patients: a potential role for Bxl-xL and alloantibody. Am J Transplant 2001, 1:260-269.
21. Jindra P., Hsueh A., Hong L., Gjertson D., Shen X.-D., Gao F., et al. Anti-MHC class I antibody activation of proliferation and survival signaling in murine cardiac allografts. J Immunol 2008, 180:2214-2224.
22. Jindra P., Jin Y., Rozengurt E., Reed E. HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway. J Immunol 2008, 180:2357-2366.
23. Jin Y., Singh R., Du Z., Rajasekaran A., Rozengurt E., Reed E. Ligation of HLA class I molecules on endothelial cells induces phosphorylation of Src, paxillin, and focal adhesion kinase in an actin-dependent manner. J Immunol 2002, 168:5415-5423.
24. Harris P., Bian H., Reed E. Induction of high affinity fibroblast growth factor receptor expression and proliferation in human endothelial cells by anti-HLA antibodies: a possible mechanism for transplant atherosclerosis. J Immunol 1997, 159:5697-5704.
25. Jin Y., Fishbein M., Said J., Jindra P., Rajalingam R., Rozengurt E., et al. Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells. Hum Immunol 2004, 65:291-302.
26. Colvin R.B., Smith R.N. Antibody-mediated organ-allograft rejection. Nat Rev Immunol 2005, 5:807-817.
27. Sis B., Jhangri G.S., Bunnag S., Allanach K., Kaplan B., Halloran P.F. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 2009, 9:2312-2323.